Caribou Biosciences Inc Cash Flow-to-Debt Ratio
Caribou Biosciences Inc cash flow-to-debt ratio. Caribou Biosciences Inc (CRBU) has a Cash Flow-to-Debt Ratio of -0.51x as of June 2026, meaning its operating cash flow of $-22.79 Million could theoretically repay -1% of its total liabilities ($44.67 Million) in one year. See Caribou Biosciences Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Caribou Biosciences Inc (2019–2025)
Cash flow-to-debt ratio of Caribou Biosciences Inc from 2019 to 2025. Historical debt coverage capacity for Caribou Biosciences Inc across 7 annual periods. Check Caribou Biosciences Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Caribou Biosciences Inc Cash Flow-to-Debt Ratio by Year (2019–2025)
Caribou Biosciences Inc cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Caribou Biosciences Inc. For the full cash flow conversion analysis, see how efficiently does Caribou Biosciences Inc generate cash.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.09x | $-110.99 Million | $53.19 Million | ▲ +8.9% |
| 2024 | -2.29x | $-138.20 Million | $60.36 Million | ▼ -56.6% |
| 2023 | -1.46x | $-93.29 Million | $63.81 Million | ▼ -17.2% |
| 2022 | -1.25x | $-90.97 Million | $72.89 Million | ▼ -109.3% |
| 2021 | -0.60x | $-32.52 Million | $54.53 Million | ▼ -6.8% |
| 2020 | -0.56x | $-33.22 Million | $59.48 Million | ▲ +5.0% |
| 2019 | -0.59x | $-32.01 Million | $54.47 Million | — |